Full metadata record

DC Field Value Language
dc.contributor.authorLee, Sangkyu-
dc.contributor.authorYoo, Hye Hyun-
dc.contributor.authorIn, Moon Kyo-
dc.contributor.authorJin, Changbae-
dc.contributor.authorKim, Dong Hyun-
dc.date.accessioned2024-01-20T11:03:49Z-
dc.date.available2024-01-20T11:03:49Z-
dc.date.created2021-09-05-
dc.date.issued2013-11-
dc.identifier.issn0253-6269-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/127471-
dc.description.abstractN,N-Dimethylamphetamine (DMA), a methamphetamine (MA) analog, is known as a weak central nervous system stimulant. As DMA possesses a chiral center, we investigated the enantioselective formation of N,N-dimethylamphetamine N-oxide (DMANO) and MA from DMA using human liver microsomes, recombinant cytochrome P450 (CYP) 2D6, and flavin monooxygenases (FMO) 1 and 3. d-DMA was preferentially metabolized to MA, whereas l-DMA was more rapidly transformed to DMANO in human liver microsomes. CYP2D6 showed a preference for catalyzing N-demethylation of d-DMA, and the intrinsic clearance (Clint) ratio of d-isomer to l-isomer was 1.41. FMO1 catalyzed the formation of slightly less d-DMANO than l-DMANO, and the Clint ratio of the d- to l-isomer was 0.78. The reverse was observed for the formation of DMANO by FMO3. However, given the minor contribution of FMO3 compared with FMO1, it would not affect the overall enantioselective formation of DMANO in human liver microsomes. Enantioselectivities in the formation of MA and DMANO in human liver microsomes were consistent with those of CYP2D6 and FMO1, respectively.-
dc.languageEnglish-
dc.publisherPHARMACEUTICAL SOC KOREA-
dc.subjectIN-VITRO METABOLISM-
dc.subjectCAPILLARY-ELECTROPHORESIS-
dc.subjectMASS SPECTROMETRY-
dc.subjectMETHAMPHETAMINE-
dc.subjectAMPHETAMINE-
dc.subjectDIMETHYLAMPHETAMINE-
dc.subjectHYDROXYLATION-
dc.subjectCYP2D6-
dc.subjectURINE-
dc.subjectRAT-
dc.titleStereoselectivity in the cytochrome P450-dependent N-demethylation and flavin monooxygenase-dependent N-oxidation of N,N-dimethylamphetamine-
dc.typeArticle-
dc.identifier.doi10.1007/s12272-013-0137-z-
dc.description.journalClass1-
dc.identifier.bibliographicCitationARCHIVES OF PHARMACAL RESEARCH, v.36, no.11, pp.1385 - 1391-
dc.citation.titleARCHIVES OF PHARMACAL RESEARCH-
dc.citation.volume36-
dc.citation.number11-
dc.citation.startPage1385-
dc.citation.endPage1391-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.identifier.kciidART001902844-
dc.identifier.wosid000326688100012-
dc.identifier.scopusid2-s2.0-84888138404-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusIN-VITRO METABOLISM-
dc.subject.keywordPlusCAPILLARY-ELECTROPHORESIS-
dc.subject.keywordPlusMASS SPECTROMETRY-
dc.subject.keywordPlusMETHAMPHETAMINE-
dc.subject.keywordPlusAMPHETAMINE-
dc.subject.keywordPlusDIMETHYLAMPHETAMINE-
dc.subject.keywordPlusHYDROXYLATION-
dc.subject.keywordPlusCYP2D6-
dc.subject.keywordPlusURINE-
dc.subject.keywordPlusRAT-
dc.subject.keywordAuthorDimethylamphetamine-
dc.subject.keywordAuthorEnantiomeric metabolism-
dc.subject.keywordAuthorCYP2D6-
dc.subject.keywordAuthorFMO1-
dc.subject.keywordAuthorFMO3-
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE